Buy EGRIFTA Tesamorelin
EGRIFTA SV™ is an injectable prescription medicine used to reduce excess hard abdominal fat (hard belly) in adult patients living with HIV and lipodystrophy. It is indeed a growth hormone-releasing factor (GHRF) analog.
DOSAGE AND ADMINISTRATION
The recommended dose of EGRIFTA™ is 2 mg injected subcutaneously once a day.
The recommended injection site is the abdomen. Injection sites should be rotated to different areas of the abdomen. So, do not inject into scar tissue, bruises, or the navel.
EGRIFTA™ must be reconstituted with the diluent provided with the product.
Reconstitute the 2 mg vial of EGRIFTA™ with 2.1 mL of diluent. Mix by rolling the vial gently in your hands for 30 seconds. Do not shake.
Detailed instructions for reconstituting EGRIFTA™ are provided in the INSTRUCTIONS FOR USE leaflet enclosed in the boxes containing EGRIFTA™ and diluent.
Administer EGRIFTA™ immediately the following reconstitution and throw away any unused EGRIFTA™ solution. If not used immediately, the reconstituted EGRIFTA™ solution should be discarded. Do not freeze or refrigerate the reconstituted EGRIFTA™ solution.
Buy more products related to HGH and Steroids from our store.